The DOI matches its Crossref record.
Insulin-Like Growth Factor Binding Proteins in the Human Circulation: A Review
Abstract
The actions and bioavailability of the insulin-like growth factors (IGFs) are regulated by a family of six IGF binding proteins. IGFBP-3, the major circulating IGFBP, is unique in combining with a glycoprotein, the acid-labile subunit (ALS), to form a ternary complex with IGF-I or IGF-II. Each component of this trimer is growth hormone-dependent, and the hypoglycemic potential of circulating IGFs appears neutralized in this form. IGFs in the complex have a greatly extended circulating half-life, their stability being conferred by the presence of ALS, which is itself very stable in the circulation. IGFBP-1 does not appear to be a carrier of IGFs, but to act as an acute modulator of their metabolic activities. In this role it can be viewed as an insulin counter-regulator, blocking 'free' insulin-like activity during fasting or hypoglycemia. IGF-I administration causes complex changes in circulating IGFBPs, so that a detailed knowledge of their regulation is essential if the therapeutic potential of IGF-I is to be optimised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Rajaram, S., Baylink, D. J., & Mohan, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0321 · Cited by 1,097
Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
Grimberg, A., & Cohen, P. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200004)183:1<1::aid-jcp1>3.0.co;2-j · Cited by 506
Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics
Kelley, K. M., Oh, Y., Gargosky, S. E., Gucev, Z., Matsumoto, T., Hwa, V., Ng, L., Simpson, D. M., & Rosenfeld, R. G. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(96)00005-2 · Cited by 479
The Insulin-Like Growth Factor Axis: A Review of Atherosclerosis and Restenosis
Bayes-Genis, A., Conover, C. A., & Schwartz, R. S. (2000) · Circulation Research · doi:10.1161/01.res.86.2.125 · Cited by 416
Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms1
Van den Berghe, G., de Zegher, F., & Bouillon, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4763 · Cited by 342
Frystyk, J., Skjærbæk, C., Vestbo, E., Fisker, S., & Ørskov, H. (1999) · Diabetes/Metabolism Research and Reviews · doi:10.1002/(sici)1520-7560(199909/10)15:5<314::aid-dmrr56>3.0.co;2-e · Cited by 304
Wheatcroft, S. B., & Kearney, M. T. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.01.002 · Cited by 278
Boisclair, Y., Rhoads, R., Ueki, I., Wang, J., & Ooi, G. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1700063 · Cited by 267
Interactions of IGF-1 with the Blood-Brain Barrier in vivo and in situ
Pan, W., & Kastin, A. J. (2000) · Neuroendocrinology · doi:10.1159/000054584 · Cited by 185
Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice
Silha, J. V., Gui, Y., & Murphy, L. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2002 · Cited by 96
Röjdmark, S., & Brismar, K. (2001) · Journal of Endocrinological Investigation · doi:10.1007/bf03343879 · Cited by 44
Brandt, K., Grünler, J., Brismar, K., & Wang, J. (2015) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.11.001 · Cited by 32
“IGFBPs have been reported to have both inhibitory and potentiating effects on IGF-I action [17–21] and Zhao et al.”
Background
Metadata
- Authors
- Baxter, R. C.
- Venue
- Hormone Research
- Publisher
- S. Karger AG
- Published
- 1994
- Volume
- 42
- Issue
- 4-5
- Pages
- 140-144
- ISSN
- 0301-0163 (ISSN-L)
- 1423-0046
- OpenAlex
- W1970373283
- Cited by
- 345
- References
- 0
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.